HSE’s Chief Clinical Officer Dr Colm Henry said there is ‘much more to fear’ from the virus than from the AstraZeneca vaccine
On Newstalk Breakfast.
HSE’s Chief Clinical Officer Dr Colm Henry said:
“AstraZeneca vaccine is a really good vaccine. I know there was bad publicity, and talk and concern over what have been a very small number of cases.
“I’d say to anybody aged 60-69 who has been offered the AstraZeneca vaccine: take it. You have much more to fear from the virus than you do from the vaccine.”
He said the blood clotting cases are ‘extraordinarily rare’, and has ‘rarely ever’ been reported in older people – hence why its use has been restricted in younger cohorts.
Australia records first fatality from blood clots linked to AstraZeneca Covid vaccine https://t.co/tBekvogmbt
— Guardian news (@guardiannews) April 16, 2021
Dr Henry said officials are also looking at whether the gap between Pfizer vaccine doses can be spread out so more adults can get their first dose quicker.
He explained: “For the Pfizer vaccine, if you look at the strict licensing of the drug, you’re allowed to give the second dose up to 42 days… but the current advice we have is up to 28 days.
“The real-world evidence… is [there’s] substantial protection after the first dose. That is not an excuse not to give the second dose, but it may well give some leeway.”